Serum anti-myelin - Associated glycoprotein antibodies in Egyptian Autistic children

Journal of Child Neurology

Volumn 23, Issue 12, 2008, Pages 1413-1418

  Mostafa, Gehan Ahmed ^a,b   El Sayed, Zeinab Awad ^a   Manal, Manal Mohamed Abd ^a   El Sayed, Mohamed Farouk ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NONE   (Egypt)

Author keywords

Anti myelin associated glycoprotein antibodies; Autism; Autoimmunity

Indexed keywords

MYELIN ASSOCIATED GLYCOPROTEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTISM; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOPATHY; RISK ASSESSMENT; RISK FACTOR;

ANTIBODIES; AUTISTIC DISORDER; BRAIN; CHILD; CHILD, PRESCHOOL; EGYPT; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INTELLIGENCE; MALE; MYELIN-ASSOCIATED GLYCOPROTEIN; RETROSPECTIVE STUDIES; SLEEP DEPRIVATION; STATISTICS, NONPARAMETRIC;

EID: 57749174019     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808319321     Document Type: Article

References (33)

1. Dalton R., Forman MA, Boris NW Pervasive developmental disorders and childhood psychosis. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17 th ed. Philadelphia, PA: WB Saunders; 2004: 93-94.
2. Xue Ming, Brimacombe M., Chaaban J., et al. Autism spectrum disorders: concurrent clinical disorders. J Child Neurol. 2008; 23: 6-13.
3. Kidd PM Autism, an extreme challenge to integrative medicine. Part 1. The knowledge base. Altern Med Rev. 2002; 7: 292-316.
4. Vojdani A., Pangborn JB, Vojdani E., Cooper EL Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int J Immunopathol Pharmacol. 2003; 16: 189-199.
5. Cohly HH, Panja A. Immunological findings in autism. Int Rev Neurobiol. 2005; 71: 317-341.
6. Vojdani A., Campbell A., Anyanwu E., et al. Antibodies to neuron-specific antigens in children with autism: Possible cross-reaction with encephalitogenic proteins form milk, Chlamydia pneumoniae and Streptococcus group A. J Neuroimmunol. 2002; 129: 168-177.
7. Mostafa GA, Refai TMK Antineuronal antibodies in autistic children: relation to blood mercury. Egypt J Pediatr Allergy Immunol. 2007; 5: 21-30.
8. Matarazzo EB Treatment of late onset autism as a consequence of probable autoimmune processes related to chronic bacterial infection. World J Biol Psychiatry. 2002; 3: 162-166.
9. Sweeten TL, Bowyer SL, Posey DJ, et al. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics. 2003; 112: E420.
10. Torres AR, Maciulis A., Odell D. The association of MHC genes with autism. Front Biosci. 2001; 6: 936-943.
11. Odell D., Maciulis A., Cutler A., et al. Confirmation of the association of C4B null allele in autism. Hum Immunol. 2005; 66: 140-145.
12. Wakefield AJ, Anthony A., Murch SH, et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol. 2000; 95: 2285-2295.
13. Aboul-Enein F., Rauschka H., Kornek B., et al. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain disease. J Neuropathol Exp Neurol. 2003; 62: 25-33.
14. Lunn MP, Crawford TO, Hughes RA, et al. Anti-myelin associated-glycoprotein antibodies alter neurofilament spacing. Brain. 2002; 125(pt 4): 904-911.
15. Cai D., Qiu J., Cao Z., et al. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci. 2001; 21: 4731-4739.
16. Steck AJ, Stalder AK, Renaud S. Anti-myelin-associated glycoprotein neuropathy. Curr Opin Neurol. 2006; 19: 458-463.
17. Monaco S., Ferrari S., Bonetti B., et al. Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex. J Neuropathol Exp Neurol. 1995; 54: 96-104.
18. Benitez-Burraco A. Autism and language: Some molecular aspects. Rev Neurol. 2008; 46: 40-48
19. Fields RD Myelination: An overlooked mechanism of synaptic plasticity. Neuroscience. 2005; 11: 528-531.
20. Bartzokis G., Lu PH, Geschwind DH, Edwards N., Mintz J., Cummings JL Apoliporotein E genotype and age-related myelin breakdown in healthy individuals: Implications for cognitive decline and dementia. Arch Gen Psychiatry. 2006; 63: 63-72.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.
22. Schopler E., Reichler RJ, Renner BR The Childhood Autism Rating Scale (CARS), for Diagnostic Screening and Classification in Autism. New York, NY: Irvington; 1986.
23. Terman LM, Merrill MA Stanford-Binet Intelligence Scale: Manual for the 3rd Revision Form L-M. Chicago, IL: The Riverside Publishing Company; 1973.
24. Nobile-Orazio E., Meucci N., Baldini A., et al. Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain. 2000; 123: 710-717.
25. Murch S. Diet, immunity and autistic spectrum disorders. J Pediatr. 2005; 146: 582-584.
26. Jaskowski TD, Prince HE, Greer RW, et al. Further comparisons of assays for detecting MAG IgM autoantibodies. J Neuroimmunol. 2007; 187: 175-178.
27. Singh VK, Lin SX, Yang VC Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol. 1998; 89: 105-108.
28. Comi AM, Zimmerman AW, Frye VH, et al. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol. 1999; 14: 388-394.
29. Jyonouchi H., Sun S., Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorders. Neuropsychobiology. 2002; 46: 76-84.
30. Mutter J., Naumann J., Schneider R., et al. Mercury and autism: accelerating evidence ? Neuro Endocrinol Lett. 2005; 26: 439-446.
31. Dochniak MJ Autism spectrum disorders: Exogenous protein insult. Med Hypotheses. 2007; 89: 545-549.
32. Renaud S., Fuhr P., Gregor M., et al. High-dose rituximab and anti-MAG associated polyneuropathy. Neurology. 2006 14; 66: 742-744
33. Benedetti L., Briani C., Grandis M., et al. Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M. J Peripher Nerv Syst. 2007; 12: 102-107.